Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021
April 15 2021 - 6:30AM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call
on Thursday, April 29, 2021 at 5:00 pm eastern time to discuss the
financial results for the first quarter of 2021, recent business
developments, revenue guidance for the second quarter of 2021, and
financial outlook for full year 2021.
This conference call can be accessed live by telephone or by
webcast:
|
Teleconference Information:Dial
in number – toll-free: (855) 766-6521Dial in
number – toll: (262) 912-6157Conference ID:
9153099 |
|
|
|
Webcast
Information: |
|
Visit
https://edge.media-server.com/mmc/p/yvrb3cpe for the live
webcast. |
A replay of the call can be accessed from the Emergent
website.
About Emergent BioSolutionsEmergent
BioSolutions is a global life sciences company whose mission is to
protect and enhance life. Through our specialty products and
contract development and manufacturing services, we are dedicated
to providing solutions that address public health threats. Through
social responsibility, we aim to build healthier and safer
communities. We aspire to deliver peace of mind to our patients and
customers so they can focus on what’s most important in their
lives. In working together, we envision protecting or enhancing 1
billion lives by 2030. For more information, visit our website and
follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G. BurrowsVice
President, Investor Relationsburrowsr@ebsi.com
Media Contact:Matt HartwigDirector, Media
Relationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Sep 2023 to Sep 2024